{name}
{subtitle}
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~15 mi. (Novara, Italy, +260 more cities)
facility
University of Eastern Piedmont - Maggiore della Carità University Hospital
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation
city
~15 mi. (Novara, Italy, +50 more cities)
facility
SCDU Ematologia
drug
obinutuzumab, +1 more drug
drug type
chemotherapy, +1 more type
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
city
~18 mi. (Trino, Italy, +81 more cities)
facility
Azienda Ospedaliera Ordine Mauriziano di Torino
drug
atezolizumab, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
city
~18 mi. (Trino, Italy, +62 more cities)
facility
Ospedale Infantile Regina Margherita - INCIPIT - PIN
biomarker
ABL1 Fusion, +31 more biomarkers
condition
Acute Lymphoblastic Leukemia, +1 more condition
drug
chemotherapy, +1 more drug
drug type
chemotherapy, +1 more type
Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
city
~18 mi. (Trino, Italy, +37 more cities)
facility
A. O. Città della Salute e della Scienza di Torino; SC Oncoematologia e Centro Trapianti AOOIRM
biomarker
NTRK1 Fusion, +3 more biomarkers
Safety and Pharmacokinetics (PK) of Escalating Doses of Tiragolumab as a Single Agent and in Combination With Atezolizumab and/or Other Anti-Cancer Therapies in Locally Advanced or Metastatic Tumors
city
~33 mi. (Cordona, Italy, +28 more cities)
facility
C.H. Regional Reina Sofia - PPDS
drug
atezolizumab, +1 more drug
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~37 mi. (Alessandria, Italy, +383 more cities)
facility
Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Investigation of Radium-223 Dichloride (Xofigo), a Treatment That Gives Off Radiation That Helps Kill Cancer Cells, Compared to a Treatment That Inactivates Hormones (New Antihormonal Therapy, NAH) in Patients With Prostate Cancer That Has Spread to the Bone Getting Worse on or After Earlier NAH
city
~37 mi. (Alessandria, Italy, +122 more cities)
facility
A.O. Nazionale SS Antonio e Biagio e Cesare Arrigo
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~37 mi. (Legnano, Italy, +156 more cities)
facility
Ospedale Civile di Legnano - ASST Ovest Milanese /ID# 222989
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type